REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,508,000 | +1.2% | 685,011 | 0.0% | 35.31% | -2.7% |
Q2 2022 | $13,351,000 | -23.6% | 685,011 | 0.0% | 36.28% | -6.4% |
Q1 2022 | $17,475,000 | +1.4% | 685,011 | 0.0% | 38.78% | +23.8% |
Q4 2021 | $17,242,000 | -8.5% | 685,011 | 0.0% | 31.32% | +12.2% |
Q3 2021 | $18,845,000 | -13.3% | 685,011 | 0.0% | 27.92% | +58.5% |
Q2 2021 | $21,742,000 | -30.8% | 685,011 | 0.0% | 17.62% | -26.8% |
Q1 2021 | $31,428,000 | +15.9% | 685,011 | 0.0% | 24.07% | +21.8% |
Q4 2020 | $27,120,000 | – | 685,011 | – | 19.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |